Devyser Diagnostics AB (FRA:OL0) LT-Debt-to-Total-Asset : 0.10 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Devyser Diagnostics AB's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.10.

Devyser Diagnostics AB's long-term debt to total assets ratio declined from Sep. 2023 (0.13) to Sep. 2024 (0.10). It may suggest that Devyser Diagnostics AB is progressively becoming less dependent on debt to grow their business.

Devyser Diagnostics AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for Devyser Diagnostics AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB LT-Debt-to-Total-Asset Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.28

0.20

0.02

0.03

0.11

Devyser Diagnostics AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial														0.13	0.11	0.11	0.10	0.10

Devyser Diagnostics AB LT-Debt-to-Total-Asset Calculation

Devyser Diagnostics AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	5.122	/	45.601
	=	0.11

Devyser Diagnostics AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	4.184	/	40.774
	=	0.10

Devyser Diagnostics AB (FRA:OL0) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Devyser Diagnostics AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

DVYSR:Sweden

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines